(1)
Kłusek, M.; Chawrylak, K.; Kuszneruk, J.; Kubas, M.; Krzemińska, K. Sodium–glucose Co-Transporter-2 Inhibitors - Empagliflozin and Dapagliflozin As Future Therapy for Alport Syndrome, Literature Review. Qual Sport 2024, 18, 53252.